Patent directory · USPTO A61K / A61P
Patents matching “treatment”
2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12291548
Compounds, compositions, and methods for the treatment of disease
granted -
US 12290651
Devices and methods for the treatment of body surface disorders
granted -
US 12290538
Methods and products for treatment of gastrointestinal disorders
granted -
US 12290596
Compositions and methods for the treatment of opioid overdose
granted -
US 12290551
Methods for imaging and treatment of somatostatin-receptor positive tumors
granted -
US 12291507
Compounds and their use for the treatment of ALPHA1-antitrypsin deficiency
granted -
US 12292445
Methods of selecting subjects for treatment with metabolomic modulators
granted -
US 12285490
ASH1L degraders and methods of treatment therewith
granted -
US 12286402
Compounds and their use for the treatment of alpha1-antitrypsin deficiency
granted -
US 12285397
Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and related compounds, (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disorders
granted -
US 12286479
Treatment with anti-α4β7 antibody
granted -
US 12286630
Treatment methods for muscular dystrophy
granted -
US 12286406
Inhibitors of receptor interacting protein kinase I for the treatment of disease
granted -
US 12286407
Estrogen receptor beta ligands for the prevention and treatment of multiple sclerosis (MS) and other demyelinating, inflammatory and neurodegenerative diseases
granted -
US 12280063
Anti-retroviral therapies and reverse transcriptase inhibitors for treatment of Alzheimer's disease
granted -
US 12279630
Treatment and prevention of seed allergies
granted -
US 12280029
Methods of treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic modulators
granted -
US 12281079
Quinoline derivatives, processes for their preparation and uses thereof for the treatment of cancer
granted -
US 12280046
Melanocortin subtype-2 receptor (MC2R) antagonist for the treatment of disease
granted -
TW 202515903
Anti-PD-1-based treatment before and after surgery
granted -
US 12274735
IL-4-fusion formulations for treatment of central nervous system (CNS) tumors
granted -
US 12275685
Oligo-benzamide analogs and their use in cancer treatment
granted -
US 12274684
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
granted -
US 12274725
Zika virus strains for treatment of glioma
granted